Kappa Bioscience

Oslo, Norway Founded: 2006 • Age: 20 yrs Acquired By Balchem
Provider of nutraceutical and vitamin ingredients
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 42 Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 6 Brand Intelligence

About Kappa Bioscience

Kappa Bioscience is a company based in Oslo (Norway) founded in 2006 was acquired by Balchem in June 2022. The company has 42 employees as of December 31, 2020. Kappa Bioscience offers products and services including K2VITAL™ and K2VITAL™ DELTA. Kappa Bioscience operates in a competitive market with competitors including Deccan Healthcare, Natto Pharma, Kingdomway, AudiaCare and Pura Vida Health, among others.

  • Headquarter Oslo, Norway
  • Employees 42 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Balchem Corporation
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    $5.44 M (USD)
    -14
    as on Dec 31, 2022
  • EBITDA
    $7.03 M (USD)
    -2
    as on Dec 31, 2022
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    42

    as on Dec 31, 2020

  • Acquired by
    Balchem

    (Jun 14, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kappa Bioscience

Kappa Bioscience offers a comprehensive portfolio of products and services, including K2VITAL™ and K2VITAL™ DELTA.

Product name locked
Category locked
Primary

Offers bioactive vitamin K2 for bone and heart health support.

Product name locked
Category locked
Locked

Provides stable, microencapsulated vitamin K2 for formulations.

Funding Insights of Kappa Bioscience

Premium access

Detailed funding history for Kappa Bioscience

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Kappa Bioscience

Kappa Bioscience has secured backing from 1 investor. Prominent investors backing the company include Balchem.

All
Investor Description Founded Year Domain Location
Nutraceutical ingredients are manufactured for human and animal nutrition products.
Locked Locked Locked
Premium access

Investor details for Kappa Bioscience

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kappa Bioscience

Investments
Premium access

Investment portfolio details for Kappa Bioscience

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kappa Bioscience

Premium access

Detailed financials for Kappa Bioscience

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kappa Bioscience Comparisons

Kappa Bioscience Primary company
Description
Provider of nutraceutical and vitamin ingredients
Location
Oslo, Norway
Founded Year
2006
Annual Revenue
Not available
Net Profit
$5.44 M (USD)
EBITDA
$7.03 M (USD)
Employees
42
As of 2020
Premium access

Peer comparison for Kappa Bioscience

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kappa Bioscience

Kappa Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Deccan Healthcare, Natto Pharma, Kingdomway, AudiaCare and Pura Vida Health, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Dietary supplements and vitamins are provided for healthy lifestyles.
Locked Locked Locked
Patented vitamin K2 ingredients are manufactured and marketed.
Locked Locked Locked
Nutraceutical ingredients including DHA and ARA are manufactured by Kingdomway.
Locked Locked Locked
Vitamins, proteins, and organic products are manufactured by AudiaCare.
Locked Locked Locked
Non-profit organization promoting digital art, cultural events, and technology innovation.
Premium access

Detailed competitors of Kappa Bioscience

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kappa Bioscience

Premium access

Complete news archive for Kappa Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kappa Bioscience

Kappa Bioscience was founded in 2006.

Kappa Bioscience is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.

Egil Greve is the current CEO of Kappa Bioscience.

As of Dec 31, 2020, the latest employee count at Kappa Bioscience is 42.

Kappa Bioscience was founded in 2006 in Oslo, Norway, as a provider in the nutraceutical sector. Ingredients and related services are offered, with a focus on bone and heart health applications. The primary product, vitamin K2 in the form of menaquinone-7 (MK-7), is supplemented by vitamin D3 and plant-derived calcium citrate. Operations center on ingredient development and supply within the health supplement industry.

Kappa Bioscience's top competitors include Kingdomway, Deccan Healthcare and Natto Pharma.

Kappa Bioscience offers K2VITAL™ and K2VITAL™ DELTA.

Kappa Bioscience has 1 investor. Key investors include Balchem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available